BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Moyret-Lalle C, Ruiz E, Puisieux A. Epithelial-mesenchymal transition transcription factors and miRNAs: “Plastic surgeons” of breast cancer. World J Clin Oncol 2014; 5(3): 311-322 [PMID: 25114847 DOI: 10.5306/wjco.v5.i3.311]
URL: https://www.wjgnet.com/2218-4333/full/v5/i3/311.htm
Number Citing Articles
1
Maitham A. Khajah, Alyaa Al-Ateyah, Yunus A. Luqmani. MicroRNA expression profiling of endocrine sensitive and resistant breast cancer cell linesBiochemistry and Biophysics Reports 2022; 31: 101316 doi: 10.1016/j.bbrep.2022.101316
2
Doaa Tawfik, Angela Zaccagnino, Alexander Bernt, Monika Szczepanowski, Wolfram Klapper, Albrecht Schwab, Holger Kalthoff, Anna Trauzold. The A818–6 system as an in-vitro model for studying the role of the transportome in pancreatic cancerBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06773-w
3
S Ingthorsson, K Andersen, B Hilmarsdottir, G M Maelandsmo, M K Magnusson, T Gudjonsson. HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFROncogene 2016; 35(32): 4244 doi: 10.1038/onc.2015.489
4
CUNEN WU, YUWEN ZHUANG, SHAN JIANG, SHENLIN LIU, JINYONG ZHOU, JIAN WU, YUHAO TENG, BAOMEI XIA, RUIPING WANG, XI ZOU. Interaction between Wnt/β-catenin pathway and microRNAs regulates epithelial-mesenchymal transition in gastric cancer (Review)International Journal of Oncology 2016; 48(6): 2236 doi: 10.3892/ijo.2016.3480
5
Z Zhang, M Zhang, Qinghan Chen, Q Zhang. Downregulation of microRNA-145 promotes epithelial–mesenchymal transition via regulating Snail in osteosarcomaCancer Gene Therapy 2017; 24(2): 83 doi: 10.1038/cgt.2017.1
6
Nastaran Mohammadi Ghahhari, Sadegh Babashah. Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial–mesenchymal transition in cancerEuropean Journal of Cancer 2015; 51(12): 1638 doi: 10.1016/j.ejca.2015.04.021
7
Wilhem Leconet, Myriam Chentouf, Stanislas du Manoir, Clément Chevalier, Audrey Sirvent, Imade Aït-Arsa, Muriel Busson, Marta Jarlier, Nina Radosevic-Robin, Charles Theillet, Dany Chalbos, Jean-Max Pasquet, André Pèlegrin, Christel Larbouret, Bruno Robert. Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and MetastasisClinical Cancer Research 2017; 23(11): 2806 doi: 10.1158/1078-0432.CCR-16-1316
8
Fei Liu, Li-Na Gu, Bao-En Shan, Cui-Zhi Geng, Mei-Xiang Sang. Biomarkers for EMT and MET in breast cancer: An updateOncology Letters 2016; 12(6): 4869 doi: 10.3892/ol.2016.5369
9
Kamoru A. Adedokun, Sikiru O. Imodoye, Ibrahim O. Bello, Abdul-Azeez Lanihun, Ibrahim O. Bello. Phytochemistry, Computational Tools and Databases in Drug Discovery2023; : 393 doi: 10.1016/B978-0-323-90593-0.00017-4
10
Hong-Liang Shen, Qing-Jun Liu, Pei-Qian Yang, Ye Tian. Protein interactions of cortactin in relation to invadopodia formation in metastatic renal clear cell carcinomaTumor Biology 2015; 36(5): 3417 doi: 10.1007/s13277-014-2976-8
11
Jie Li, Xia Gong, Rong Jiang, Dan Lin, Tao Zhou, Aijie Zhang, Hongzhong Li, Xiang Zhang, Jingyuan Wan, Ge Kuang, Hongyuan Li. Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal PathwayFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00772
12
Evgeny V. Denisov, Mohit Kumar Jolly, Vitaly P. Shubin, Alexey S. Tsukanov, Nadezhda V. Cherdyntseva. Approaching Complex DiseasesHuman Perspectives in Health Sciences and Technology 2020; 2: 213 doi: 10.1007/978-3-030-32857-3_10
13
Shilpa R. Raju, Sreenath Balakrishnan, Somanna Kollimada, K.N. Chandrashekara, Aruna Jampani. Anti-tumor effects of Artemisia nilagirica extract on MDA-MB-231 breast cancer cells: deciphering the biochemical and biomechanical properties via TGF-β upregulationHeliyon 2020; 6(10): e05088 doi: 10.1016/j.heliyon.2020.e05088
14
ALAN P. LOMBARD, REBECCA M. LIM, RACHEL M. NAKAGAWA, KATHLEEN D. VIDALLO, STEPHEN J. LIBERTINI, ALEXANDER J. PLATERO, MARIA MUDRYJ. Dicer ablation promotes a mesenchymal and invasive phenotype in bladder cancer cellsOncology Reports 2015; 34(3): 1526 doi: 10.3892/or.2015.4117
15
Javier Vaquero, Nathalie Guedj, Audrey Clapéron, Thanh Huong Nguyen Ho-Bouldoires, Valérie Paradis, Laura Fouassier. Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networksJournal of Hepatology 2017; 66(2): 424 doi: 10.1016/j.jhep.2016.09.010
16
Megan Mladinich, Diane Ruan, Chia-Hsin Chan. Tackling Cancer Stem Cells via Inhibition of EMT Transcription FactorsStem Cells International 2016; 2016: 1 doi: 10.1155/2016/5285892
17
Busra Buyuk, Sha Jin, Kaiming Ye. Epithelial-to-Mesenchymal Transition Signaling Pathways Responsible for Breast Cancer MetastasisCellular and Molecular Bioengineering 2022; 15(1): 1 doi: 10.1007/s12195-021-00694-9
18
Lenka Kalinkova, Nataliia Nikolaieva, Bozena Smolkova, Sona Ciernikova, Karol Kajo, Vladimir Bella, Viera Horvathova Kajabova, Helena Kosnacova, Gabriel Minarik, Ivana Fridrichova. miR-205-5p Downregulation and ZEB1 Upregulation Characterize the Disseminated Tumor Cells in Patients with Invasive Ductal Breast CancerInternational Journal of Molecular Sciences 2021; 23(1): 103 doi: 10.3390/ijms23010103
19
Neda Alidadiani, Shahrooz Ghaderi, Nafi Dilaver, Saina Bakhshamin, Mansour Bayat. Epithelial mesenchymal transition Transcription Factor (TF): The structure, function and microRNA feedback loopGene 2018; 674: 115 doi: 10.1016/j.gene.2018.06.049
20
Shaohua Chen, Daohai Zhang. Friend or foe: Endoplasmic reticulum protein 29 (ERp29) in epithelial cancerFEBS Open Bio 2015; 5(1): 91 doi: 10.1016/j.fob.2015.01.004
21
Caroline Moyret-Lalle, Roxane Pommier, Charlotte Bouard, Ebticem Nouri, Geoffrey Richard, Alain Puisieux. Plasticité des cellules cancéreuses et dissémination métastatiquemédecine/sciences 2016; 32(8-9): 725 doi: 10.1051/medsci/20163208020
22
R. Portillo-Lara, N. Annabi. Microengineered cancer-on-a-chip platforms to study the metastatic microenvironmentLab on a Chip 2016; 16(21): 4063 doi: 10.1039/C6LC00718J
23
Han-xiang Zhan, Jian-wei Xu, Dong Wu, Tai-ping Zhang, San-yuan Hu. Pancreatic cancer stem cells: New insight into a stubborn diseaseCancer Letters 2015; 357(2): 429 doi: 10.1016/j.canlet.2014.12.004
24
Xianlu Zhuo, Huanli Luo, Aoshuang Chang, Dairong Li, Houyu Zhao, Qi Zhou. Is overexpression of TWIST, a transcriptional factor, a prognostic biomarker of head and neck carcinoma? Evidence from fifteen studiesScientific Reports 2015; 5(1) doi: 10.1038/srep18073
25
Ivana Fridrichova, Iveta Zmetakova. MicroRNAs Contribute to Breast Cancer InvasivenessCells 2019; 8(11): 1361 doi: 10.3390/cells8111361
26
Siri Amanda Tvingsholm, Ditte Marie Brix, Tuula Kallunki. Molecular and Transcriptional Signatures for ErbB2-Induced InvasionCurrent Pharmacology Reports 2019; 5(1): 43 doi: 10.1007/s40495-018-0146-1
27
Shravanti Mukherjee, Shilpi Saha, Argha Manna, Minakshi Mazumdar, Samik Chakraborty, Shrutarshi Paul, Tanya Das. Targeting Cancer Stem Cells by Phytochemicals: a Multimodal Approach to Colorectal CancerCurrent Colorectal Cancer Reports 2014; 10(4): 431 doi: 10.1007/s11888-014-0251-4
28
Ivana Fridrichova, Lenka Kalinkova, Sona Ciernikova. Clinical Relevancy of Circulating Tumor Cells in Breast Cancer: Epithelial or Mesenchymal Characteristics, Single Cells or Clusters?International Journal of Molecular Sciences 2022; 23(20): 12141 doi: 10.3390/ijms232012141
29
Maxime Janin, Veronica Davalos, Manel Esteller. Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomicsCancer and Metastasis Reviews 2023; 42(4): 1071 doi: 10.1007/s10555-023-10120-3
30
Zhengjie Lin, Guanyi Luo, Weixiang Du, Tiantian Kong, Changkun Liu, Zhou Liu. Recent Advances in Microfluidic Platforms Applied in Cancer Metastasis: Circulating Tumor Cells' (CTCs) Isolation and Tumor‐On‐A‐ChipSmall 2020; 16(9) doi: 10.1002/smll.201903899
31
Yuechao Zhao, Yiran Li, Jie Sheng, Fan Wu, Kai Li, Rong Huang, Xiaojuan Wang, Tao Jiao, Xin Guan, Yan Lu, Xiao Chen, Zhiwen Luo, Yanchi Zhou, Hanjie Hu, Wenjie Liu, Boyu Du, Shiying Miao, Jianqiang Cai, Linfang Wang, Hong Zhao, Jianming Ying, Xinyu Bi, Wei Song. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAsJournal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1375-9
32
Xi Gu, Jin-Qi Xue, Si-Jia Han, Song-Ying Qian, Wen-Hai Zhang. Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancerCancer Biomarkers 2016; 16(3): 395 doi: 10.3233/CBM-160578
33
Zhe Zhang, Guojun Zhang, Chuize Kong, Jianbin Bi, Daxin Gong, Xiuyue Yu, Du Shi, Bo Zhan, Peng Ye. EIF2C, Dicer, and Drosha are up-regulated along tumor progression and associated with poor prognosis in bladder carcinomaTumor Biology 2015; 36(7): 5071 doi: 10.1007/s13277-015-3158-z
34
Suman Kumar Ray, Sukhes Mukherjee. Epigenetic Reprogramming and Landscape of Transcriptomic Interactions: Impending Therapeutic Interference of Triple-Negative Breast Cancer in Molecular MedicineCurrent Molecular Medicine 2022; 22(10): 835 doi: 10.2174/1566524021666211206092437
35
Mohammed A. Aleskandarany, Ian O. Ellis, Emad A. Rakha. Precision Molecular Pathology of Breast CancerMolecular Pathology Library 2015; 10: 271 doi: 10.1007/978-1-4939-2886-6_16
36
Sugandha Bhatia, James Monkman, Alan Kie Leong Toh, Shivashankar H. Nagaraj, Erik W. Thompson. Targeting epithelial–mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoringBiochemical Journal 2017; 474(19): 3269 doi: 10.1042/BCJ20160782
37
Riccardo Di Fiore, Rosa Drago-Ferrante, Francesca Pentimalli, Domenico Di Marzo, Iris Maria Forte, Daniela Carlisi, Anna De Blasio, Giovanni Tesoriere, Antonio Giordano, Renza Vento. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem CellsJournal of Cellular Physiology 2016; 231(8): 1832 doi: 10.1002/jcp.25291
38
Mariana Segovia-Mendoza, Susana Romero-Garcia, Cristina Lemini, Heriberto Prado-Garcia, francesca bianchi. Determining Factors in the Therapeutic Success of Checkpoint Immunotherapies against PD-L1 in Breast Cancer: A Focus on Epithelial-Mesenchymal Transition ActivationJournal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/6668573
39
Michel-Gael F. Guefack, Debojit Talukdar, Rimi Mukherjee, Subhabrata Guha, Debarpan Mitra, Depanwita Saha, Gaurav Das, François Damen, Victor Kuete, Nabendu Murmu. Hypericum roeperianum bark extract suppresses breast cancer proliferation via induction of apoptosis, downregulation of PI3K/Akt/mTOR signaling cascade and reversal of EMTJournal of Ethnopharmacology 2024; 319: 117093 doi: 10.1016/j.jep.2023.117093
40
Faezeh Karami, Narges Maleki, Arefeh Khazraei Monfared, Sayeh Jafari Marandi. Upregulation of miR-206 is a potential diagnostic biomarker in breast cancerBionatura 2021; 6(2): 1757 doi: 10.21931/RB/2021.06.02.15
41
Chloé Morin, Caroline Moyret-Lalle, Hichem C. Mertani, Jean-Jacques Diaz, Virginie Marcel. Heterogeneity and dynamic of EMT through the plasticity of ribosome and mRNA translationBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(3): 188718 doi: 10.1016/j.bbcan.2022.188718
42
Saevar Ingthorsson, Eirikur Briem, Jon Thor Bergthorsson, Thorarinn Gudjonsson. Epithelial Plasticity During Human Breast Morphogenesis and Cancer ProgressionJournal of Mammary Gland Biology and Neoplasia 2016; 21(3-4): 139 doi: 10.1007/s10911-016-9366-3
43
Manish Ranjan, Oukseub Lee, Gannon Cottone, Elnaz Mirzaei Mehrabad, Benjamin T. Spike, Zexian Zeng, Shivangi Yadav, Robert Chatterton, J. Julie Kim, Susan E. Clare, Seema A. Khan. Progesterone receptor antagonists reverse stem cell expansion and the paracrine effectors of progesterone action in the mouse mammary glandBreast Cancer Research 2021; 23(1) doi: 10.1186/s13058-021-01455-2
44
Abhishek Mukherjee, Patrick Ha, Katherine C. Wai, Shorook Naara. The Role of ECM Remodeling, EMT, and Adhesion Molecules in Cancerous Neural Invasion: Changing PerspectivesAdvanced Biology 2022; 6(9) doi: 10.1002/adbi.202200039
45
Minal Garg. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasisExpert Reviews in Molecular Medicine 2017; 19 doi: 10.1017/erm.2017.6